Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 3Suspended 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 1Lung Neoplasms 1Hematopoietic and Lymphoid System Neoplasm 1

Interventions

Cisplatin 3pembrolizumab 2Etoposide 2Docetaxel 2Carboplatin 2durvalumab 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radionuclide Imaging 1Radiation 1Prednisone 1Positron-Emission Tomography 1Platinum 1Paclitaxel 1Nivolumab 1Methods 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Injections 1Exercise Therapy 1Erlotinib Hydrochloride 1Eflornithine 1Clinical Protocols 1CTLA-4 Antigen 1Blood Specimen Collection 1Biopsy 1Biological Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Lung Neoplasms × Positron-Emission Tomography × Clear all
NCT04017819 2025-11-05

Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4

Stanford University

Phase 1 Suspended
20 enrolled
Thoracic

Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡